Pancras C.W. Hogendoorn
Researcher Next ID · RN-007724
Researcher · Medicine
Brussels, Belgium
- Works count
- 636
- Citation count
- 41,059
- H-index
- 107
- i10-index
- 387
Research interests
Publications
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70063-4
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
The Journal of Pathology · 2011 · https://doi.org/10.1002/path.2913
Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
Cancer Research · 2009 · https://doi.org/10.1158/0008-5472.can-08-3845
The Clinical Approach Towards Chondrosarcoma
The Oncologist · 2008 · https://doi.org/10.1634/theoncologist.2007-0237
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial
The Lancet · 2004 · https://doi.org/10.1016/s0140-6736(04)17098-0
Current projects
No projects listed.